Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.370
-0.020 (-0.84%)
Nov 20, 2024, 4:00 PM EST - Market closed
Acumen Pharmaceuticals Employees
As of December 31, 2023, Acumen Pharmaceuticals had 52 total employees, including 51 full-time and 1 part-time employees. The number of employees increased by 12 or 30.00% compared to the previous year.
Employees
52
Change (1Y)
12
Growth (1Y)
30.00%
Revenue / Employee
n/a
Profits / Employee
-$1,570,615
Market Cap
142.39M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 52 | 12 | 30.00% |
| Dec 31, 2022 | 40 | 23 | 135.29% |
| Dec 31, 2021 | 17 | 10 | 142.86% |
| Dec 31, 2020 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 185 |
| Pro-Dex | 148 |
| Seer, Inc. | 147 |
| Cabaletta Bio | 103 |
| PepGen | 64 |
| Sensus Healthcare | 35 |
| Zentek | 24 |
| Skye Bioscience | 11 |
ABOS News
- 8 days ago - Acumen Pharmaceuticals, Inc. (ABOS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference - GlobeNewsWire
- 14 days ago - Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference - GlobeNewsWire
- 20 days ago - Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease Conference - GlobeNewsWire
- 4 weeks ago - Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference - GlobeNewsWire
- 5 weeks ago - Lucy Therapeutics Appoints Kim Drapkin as Board Chair - Business Wire
- 7 weeks ago - Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - GlobeNewsWire
- 2 months ago - Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024 - GlobeNewsWire